Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.
about
Active surveillance and focal therapy for low-intermediate risk prostate cancerEpigenomic profiling of prostate cancer identifies differentially methylated genes in TMPRSS2:ERG fusion-positive versus fusion-negative tumors.Prognostic outlier genes for enhanced prostate cancer treatment.Analysis of Fascin-1 in Relation to Gleason Risk Classification and Nuclear ETS-Related Gene Status of Human Prostate Carcinomas: An Immunohistochemical Study of Clinically Annotated Tumours From the Wales Cancer Bank.Translating RNA sequencing into clinical diagnostics: opportunities and challenges.TMPRSS2:ERG gene aberrations may provide insight into pT stage in prostate cancer.Noninvasive Prenatal Diagnosis Significance of ERG Methylation as a Biomarker in Down's SyndromeMolecular biomarkers to guide precision medicine in localized prostate cancer.TMPRSS2:ERG fusion gene occurs less frequently in Chinese patients with prostate cancer.ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer.Expression of ERG Protein and TMRPSS2-ERG Fusion in Prostatic Carcinoma in Egyptian Patients.ERG overexpression plus SLC45A3 (prostein) and PTEN expression loss: Strong association of the triple hit phenotype with an aggressive pathway of prostate cancer progression.PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients.Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion.The Role of Immunohistochemical Analysis as a Tool for the Diagnosis, Prognostic Evaluation and Treatment of Prostate Cancer: A Systematic Review of the LiteratureHigh concordance of TMPRSS-ERG fusion between primary prostate cancer and its lymph node metastasesThe positive immunostaining of TMPRSS2-ERG is not associated with unfavourable outcomes and biochemical recurrence after radical prostatectomy in Turkish patients
P2860
Q26773641-B7521A7E-0670-4D15-B765-BC09C65F8E13Q27323950-64657F23-8EF4-4511-B0BB-1B018122221BQ30244674-25BE3FCB-9F72-4025-B0A9-BE45BCBE0579Q33459386-B9662028-3CCA-49B7-998C-AF4E10E6CCEBQ34519034-4021C7FD-CE75-4C70-B7E4-55B72299F0FCQ36067872-D48030E1-128B-4FEC-B069-2356B9C2A0B1Q37616062-475D0725-2285-4505-B252-AECD46090CD0Q38668635-A74F9832-3723-40AD-BDB0-4DFCE5DAA977Q38805821-D1D9FDA7-29DE-4DF1-B546-4CCD26A07CF7Q38806608-5D70E3C5-D573-430D-8166-8899EB3D850DQ42287150-9EABBEB2-6DC3-4D89-85EB-9CC9C8B8D910Q43269413-D01B5FAE-4BF9-4BBF-8014-312626A20C47Q47104255-91F5AC27-7B39-4C1A-86A5-646592E6BE9FQ48087902-7CD1A631-D540-420F-B608-72EC938FA390Q57073785-AE8419F1-7ED1-44F4-8DE8-B2188AFB4960Q58573182-0E5A96D4-B11D-4C5E-A81C-55F1F19CDD9EQ58578862-5960FA30-67E3-4860-8DAB-CCAE6E280022
P2860
Association of ERG and TMPRSS2-ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@en
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@nl
type
label
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@en
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@nl
prefLabel
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@en
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@nl
P2093
P2860
P50
P356
P1433
P1476
Association of ERG and TMPRSS2 ...... nt on their expression levels.
@en
P2093
Josep Lloreta
Laia Serrano
Marta Lorenzo
Núria Juanpere
Sergio Serrano
Silvia Hernández
Silvia de Muga
P2860
P304
P356
10.1002/PROS.23004
P577
2015-05-04T00:00:00Z